371. Fung-Tomc J. In vitro antibacterial spectrum of a new broad-spectrum
8-methoxyfluoroquinolone, gatifloxacin / J. Fung-Tomc, B. Minassian, B. Kolek et
ai. // J. Antimicrob. Chemother. - 2000. - Vol. 45. - P. 437-446.
372. Furet J. Hepatite mixte a la rifamycine SV A propos d ’un CAS / J.
Furet // Therapie. - 1986. - Vol. 41, № 5. - P. 405-406.
374. Furin J.J. Occurrence of serious adverse effects in patients received
community-based therapy for multidrug-resistant tuberculosis / J.J. Furin, C.D.
Mitnik, S.S. Shin et al. // Int. J. Tuberc. and Lang Dis. - 2001. - Vol. 5, № 7. - P.
648-655.
375. Galinier M. Depressed low frequency power of heart rate variability as
an independent predictor of sudden death in chronic heart failure / M. Galinier, A.
Pathak, J. Fourcade / Eur. Heart J. - 2000. - Vol. 21. - P.475-482.
376. Gillespie S.H. Activity of moxifloxacin against mycobacteria / S.H.
Gillespi, N. Kennedy // Int. J. Tuberc. Lung. Dis. - 1998. - Vol. 2, № 4. - P. 265-
271.
377. Goluboviz S. Frequency of resistance to antituberculosis drugs in 2003
year / S. Goluboviz, I. Djorjeviz // Europ. Resp. J. - 2004. - Vol. 28, Suppl. 48. -
P 3976.
378. Gottieb J.E. Perspective: preventive isoniazid therapy and the liver /
J.E. Gottieb, W.C. Maddrey // Chest. - 1992. - Vol. 41, № 5. - P. 1298-1301.
379. Guidelines for the Management of Multidrag-Resistant tuberculosis. -
WHO, 2 0 0 3 .- 124 p.
380. Gunning M.G. Simultaneous assessment of myocardial viability and
function for the detection of hibernating myocardium using ECG-gated 99Tc -
tetrofosmin emission tomography cjmbined with cine magnetic resonance imaging
M.G. Gunning, G. Davies et al. // Nucl. Med. Commun. - 1999. - Vol. 20, № 3. -
P 209-214.
381. Gupta R. Tuberculosis as a major global health problem in the XXI
century, a WHO perspective / R. Gupta, M. Espinal, M. Raviglione // Seminars in
respiratory and critical med. - 2004. - Vol. 24, № 3. - P. 245-253.
397
